Peptide stacking, taking two or more peptides together, rests on almost no direct evidence. Popular stacks such as CJC-1295 with ipamorelin, or BPC-157 with TB-500, have never been tested together in a human clinical trial for muscle, fat loss, healing or safety. The one controlled test of BPC-157 plus TB-500, in rats, found the pair did no better than TB-500 alone.[7]
Combinations can work, but they have to be tested properly. CagriSema, a combination of cagrilintide and semaglutide, was compared head to head with each drug alone and with placebo in 3,417 people before it was submitted to FDA.[1] No popular wellness stack has had anything like that. This guide covers what’s known, the interaction risks and how to approach combinations safely. For background, see our peptide basics hub.
Evidence-graded table
| Stack or combination | Evidence level | What was shown | FDA status | Our profile or guide |
|---|---|---|---|---|
| Cagrilintide + semaglutide (CagriSema) | Human RCTs | 20.4% weight loss vs 3.0% on placebo at 68 weeks, with single-drug arms[1] | Not yet approved | Cagrilintide |
| GHRH-type + GHRP-type peptides | Small human studies | More GH released together than alone, in single-dose studies[2][3] | Not applicable (research) | CJC-1295 + ipamorelin |
| CJC-1295 + ipamorelin | No evidence, marketing only | No published combination trial | Neither approved[5][6] | CJC-1295 + ipamorelin |
| BPC-157 + TB-500 (“Wolverine”) | Animal or lab only | Rat tendons: no benefit beyond TB-500 alone[7] | Neither approved[8] | Wolverine stack |
| GLOW and KLOW blends | No evidence, marketing only | No trials of the blends | Not approved | GLOW blend |
| MK-677 + other GH boosters | No evidence for the combination | MK-677 alone raised blood sugar[9] | Not approved; FDA safety-risk list[13] | MK-677 |
Why “synergy” claims are thin
The case for CJC-1295 with ipamorelin comes from real physiology. Growth hormone release is controlled by two signals: GHRH (which CJC-1295 copies) and ghrelin (which ipamorelin and other GHRPs copy). In 1990, researchers showed that giving a GHRP and GHRH together released more growth hormone in healthy men than either alone.[2] A 1995 study with GHRP-2 found the same.[3]
But those studies measured growth hormone in the blood for a few hours after one dose. CJC-1295’s own human study measured hormone levels too, not muscle or fat.[4] A bigger hormone spike is not the same as a health benefit, and no study has followed people on the stack for months. FDA’s advisers voted against allowing ipamorelin and CJC-1295 in pharmacy compounding in 2024.[5][6] Compare GH options in MK-677 vs CJC-1295/ipamorelin.
The Wolverine stack is weaker still. Each peptide has animal data on its own, and the only controlled test of the pair, in rats with tendon injuries, found statistically significant improvement with TB-500 alone and no extra benefit when BPC-157 was added.[7] FDA advisers voted in July 2026 to recommend allowing both in compounding, but the vote is not binding and neither peptide is approved.[8]
What proper combination testing looks like
REDEFINE 1, the main CagriSema trial, shows how a combination should be studied. People were randomly assigned to the combination, to semaglutide alone, to cagrilintide alone or to placebo, so researchers could see whether the pair beat each part. It produced 20.4% average weight loss versus 3.0% on placebo over 68 weeks.[1] It also measured the cost: gastrointestinal side effects such as nausea, vomiting and diarrhea affected 79.6% of people on the combination versus 39.9% on placebo.[1]
That design answers three questions DIY stacks never do: does the combination work better than either part, how much worse are the side effects, and at what doses? Without those answers, a stack is a guess.
Interaction risks nobody has tested
When two drugs are studied together, researchers look for interactions. With stacks, nobody has. Known effects of individual peptides point to several risks:
- Overlapping hormone effects. Stacking two growth hormone boosters can push IGF-1 higher than either alone. MK-677 by itself raised fasting blood sugar and lowered insulin sensitivity in older adults.[9]
- Low blood sugar. GLP-1 drugs can cause hypoglycemia when combined with insulin or sulfonylureas, and their labels advise considering lower doses of those drugs.[10]
- Absorption of oral medicines. GLP-1 drugs and bremelanotide slow stomach emptying, which can change how pills are absorbed.[10][11] Bremelanotide also sharply lowers levels of oral naltrexone, used for alcohol and opioid addiction.[11]
- Doubling the same pathway. Wegovy’s label says it should not be combined with other GLP-1 drugs.[10] Similarly, bremelanotide and melanotan II both act on melanocortin receptors; bremelanotide raises blood pressure briefly,[11] and melanotan use has been linked to changes in moles.[12]
- More products, more contamination. Each additional vial is another chance of impurities. Tests of falsified peptide drugs have found purity as low as 5% and toxic metals.[14]
- Unknown mixtures. Combining peptides in one vial can affect stability, and nobody has tested most DIY blends for that.
A 2026 review of unregulated injectable peptides warned that inaccurate dosing, contamination and supraphysiological hormone signaling compound one another.[15]
GLP-1 drugs plus “add-on” peptides
A newer trend pairs a GLP-1 drug with other peptides marketed to protect muscle, speed fat loss or ease side effects. Some compounded GLP-1 products even come premixed with additives such as vitamin B12 or amino acids. None of these combinations has been tested in trials, and the GLP-1 interaction cautions above still apply.[10] Muscle loss during weight loss is a real concern, but the best-supported ways to limit it are resistance training and adequate protein, not an extra injection. Read our guides on GLP-1 muscle loss and compounded GLP-1 additives for details.
If you’re considering a combination
- Start with the diagnosis. Approved drugs for a confirmed condition come first.
- Add one thing at a time. If side effects appear, you’ll know what caused them.
- Tell every clinician everything, including supplements and products bought online.
- Ask about the combination specifically, not just each drug alone.
Our guides on peptide cycling, peptide side effects, how to choose a peptide and are peptides safe? go deeper.
